GlassScriptPhysician profile
Robert Michael Kohut
NPI 1639331622
$3,504.53
in general payments reported to CMS, 2019-2025
20 companies · $594 in 2025
The $594 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $16.39 · 2021: $50.28 · 2022: $235 · 2023: $1,825 · 2024: $648 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853 · Travel and Lodging: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.51 |
| Travel and Lodging | $1,213.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,779.72 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $237.45 | 2022-2024 | Myrbetriq |
| Antares Pharma, INC. | $162.25 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Abbvie INC. | $152.81 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $151.26 | 2023-2024 | Gemtesa |
| Boston Scientific Corporation | $144.01 | 2021-2025 | Spaceoar Vue System - 10ml |
| Neotract INC. | $136.04 | 2019 | |
| Urogen Pharma, INC. | $109.18 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $92.33 | 2023-2025 | Myrisk, Prolaris |
| Coloplast Corp | $87.49 | 2020-2025 | |
| 180 Medical, INC. | $84.16 | 2024 | |
| Convatec INC. | $79.72 | 2024 | |
| Dentsply Ih Ab | $72.78 | 2023-2025 | Lofric, Lofric |
| Tolmar, INC. | $69.28 | 2025 | Jatenzo |
| Amgen INC. | $44.60 | 2022-2024 | Prolia |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $29.22 | 2023 | |
| Ferring Pharmaceuticals INC. | $21.17 | 2025 | Adstiladrin |
| Olympus America INC. | $18.03 | 2025 | Itind System |
| Progenics Pharmaceuticals, INC. | $17.93 | 2023 | Pylarify |
| Axonics, INC. | $15.10 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kohut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.